No Prescription |
 |
 | ||
|
Plermin Regranex |
|
| ||
No Prescription » Prescription Drugs 13 » Plermin Regranex This medication is used to treat certain foot/leg ulcers in people with diabetes. It is used along with good foot/leg care (e.g. keeping pressure off the wound) to help the ulcer heal completely. Becaplermin works by attracting certain natural substances to the ulcer that help wound healing.How to use Becaplermin TopWash hands thoroughly before applying this medicine. To avoid contaminating the container tip do not touch it to the skin or any other surface. Learn all preparation and usage instructions in the product package. If any of the information is unclear consult your doctor or pharmacist.The amount of the medication applied is based on the size of the ulcer. Your doctor or wound specialist should adjust your dose every 1 to 2 weeks.Squeeze the prescribed amount of medication onto a clean firm and non-absorbent surface (e.g. waxed paper). Use a clean applicator (e.g. cotton swab tongue depressor) to apply a thin layer of the medication evenly over the ulcer usually once daily or as directed by your doctor.Cover the ulcer with wound dressing as directed by your doctor. After 12 hours remove the dressing rinse the ulcer and apply new dressing on the ulcer. Do not apply more medication at this time.Use this medication regularly in order to get the most benefit from it. To help you remember use it at the same time each day. Use this medication until the ulcer heals completely.Do not apply a thick layer of the medication. This will not increase the effects of the medication or help the wound heal faster.Tell your doctor if your condition worsens does not improve after 10 weeks or does not heal completely after 20 weeks.What conditions does this medication treat?Becaplermin Top is used to treat the following:Ulcer of the Leg with Diabetes and Nerve Involvement Buy Plermin Regranex and other Prescription Drugs 13 products online at Medstore. Buy Online at Medstore - Click Here!
About Plermin Regranex: Product Type: Prescription Drugs 13 Plermin ( Regranex Generic Becaplermin ) Plermin (Regranex Generic Becaplermin) Regranex Generic Becaplermin 1% w/v Regranex Generic Becaplermin Plermin
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
